Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
December 20, 2021

Targeted intervention of melanoma by reprogramming...

Gender is an important factor in patients with melanoma. Female melanoma patients have an advantage over their male counterparts in terms of survival. However, the reason f...

2 Minute Read
December 20, 2021

Therapeutic Resistance to CDK4/6 inhibitors in BRA...

In the U.S. alone during 2021, an estimated 106,110 and 101,280 people will be diagnosed with invasive and non-invasive (in situ) melanoma, respectively. Moreover, it is ex...

2 Minute Read
December 20, 2021

Analysis and Expansion of the Pediatric Melanoma O...

Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) grow out of control. It is more dangerous than most o...

3 Minute Read
December 20, 2021

Immunotherapy using personalized T cell receptor e...

Immunotherapy has fundamentally changed the way we treat melanoma patients. Checkpoint blockade specifically, which unleashes T cell killing of cancer cells, has extended p...

2 Minute Read
December 20, 2021

Targeting metabolic vulnerabilities of melanoma me...

The major reason melanoma causes illness and death in patients is because the melanoma cells from the skin can travel to lymph nodes or into the blood which allows them to ...

2 Minute Read
December 20, 2021

Harnessing Epigenetic therapies to License Melanom...

Therapies that inhibit epigenetic modulators can induce a state of “virus mimicry” in cancer cells by activating long-overlooked “junk DNA” of the human genome. Thi...

1 Minute Read
December 20, 2020

CXCL9 as an Immune Anti-Melanoma Therapy in Combin...

A major obstacle to even the best melanoma therapies is that in the majority of cases, the tumor never completely goes away. Even if a little bit remains, called the minima...

3 Minute Read
December 20, 2020

Identification of Metastatic Modulators through Ze...

Melanomas arise from pigmented cells called melanocytes, typically in the skin. Melanomas can spread to distal parts of the body, through a process called metastasis. Metas...

3 Minute Read
December 20, 2020

Elucidating Metabolic Changes that Occur in Melano...

Melanoma is the third most common malignancy to metastasize to the brain. It is estimated that at least 50% of patients with stage IV melanoma will develop brain metastases...

2 Minute Read
December 20, 2019

Therapeutic Strategies to Induce Dormancy in Disse...

Metastasis is the main cause of melanoma death. Current treatments mostly fail to cure metastasis. It is of common knowledge that disseminated cancer cells (DCCs)...

2 Minute Read
December 20, 2019

Role of PRAME in Epigenetic Reprogramming and Chro...

UM has a propensity to undergo early micrometastasis prior to treatment of the primary tumor, with later emergence of overt metastatic disease. Unfortunately, the...

2 Minute Read
December 20, 2019

Augmenting Melanoma Response to Immunotherapy via ...

Cancer immunotherapy (CI) drugs activate our own immune system to directly kill cancer cells. These drugs have revolutionized how we treat many cancers including melanoma....

2 Minute Read

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Oct 30, 2025 ET

24th Annual New York Gala

Nov 02, 2025 ET

Atlanta Miles for Melanoma 5K

Explore Events